Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cancer Pain × Nerve Growth Factor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Surveys and Questionnaires 1 Polyethylene Glycols 1 Pharmacogenomic Testing 1 Oxycodone 1 Nerve Growth Factor 1 Magnesium Hydroxide 1 Fentanyl 1 Electrolytes 1 Dosage Forms 1 Control Groups 1 Antibodies 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07008703 2025-06-06

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

Shenyang Sunshine Pharmaceutical Co., LTD.

Phase 1/2 Recruiting

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡